Quetiapine was found to improve the decrease in BDNF-positive cells in the basolateral amygdala and hippocampus of transgenic models of mice with Alzheimer’s disease (43) through its modulating effects on neuroprotective factors such as reducing demyelination and increasing BDNF (44). This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.